Ditchcarbon
  • Contact
  1. Organizations
  2. Cuu Long Pharmaceutical Joint Stock Company
Public Profile
Pharmaceutical Preparation Manufacturing
VN
updated a month ago

Cuu Long Pharmaceutical Joint Stock Company Sustainability Profile

Company website

Cuu Long Pharmaceutical Joint Stock Company, commonly referred to as Cuu Long Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2001, the company has made significant strides in the production and distribution of high-quality pharmaceutical products across various regions in Vietnam. Cuu Long Pharma focuses on the development of generic medicines, herbal products, and dietary supplements, setting itself apart with a commitment to innovation and quality. The company has achieved notable milestones, including certifications from international quality standards, which bolster its reputation in the market. With a strong market position, Cuu Long Pharmaceutical is recognised for its extensive product range and dedication to improving healthcare outcomes. Its unique offerings and strategic operational approach have solidified its status as a trusted name in the Vietnamese pharmaceutical landscape.

DitchCarbon Score

How does Cuu Long Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Cuu Long Pharmaceutical Joint Stock Company's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Cuu Long Pharmaceutical Joint Stock Company's reported carbon emissions

Cuu Long Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cuu Long Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Cuu Long Pharmaceutical's position relative to industry standards. As the company moves forward, establishing measurable climate commitments and reporting emissions could enhance its sustainability profile and align it with global climate goals.

How Carbon Intensive is Cuu Long Pharmaceutical Joint Stock Company's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cuu Long Pharmaceutical Joint Stock Company's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Cuu Long Pharmaceutical Joint Stock Company's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cuu Long Pharmaceutical Joint Stock Company is in VN, which we do not have grid emissions data for.

Cuu Long Pharmaceutical Joint Stock Company's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Cuu Long Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Cuu Long Pharmaceutical Joint Stock Company's Emissions with Industry Peers

Imexpharm Corporation

VN
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

MEKOPHAR Chemical Pharmaceutical Joint Stock Company

VN
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Pymepharco Joint Stock Company

VN
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy